Home

Tilsvarende Match bagagerum cnbc teva Intakt taktik Genre

JPMorgan downgrades Teva as generic medication business struggles
JPMorgan downgrades Teva as generic medication business struggles

cnbc-teva-superJumbo.png
cnbc-teva-superJumbo.png

Teva Pharmaceuticals CEO on the Covid-19 vaccine rollout in Israel
Teva Pharmaceuticals CEO on the Covid-19 vaccine rollout in Israel

Watch CNBC's full interview with Teva Pharmaceuticals CEO Kare Schultz -  YouTube
Watch CNBC's full interview with Teva Pharmaceuticals CEO Kare Schultz - YouTube

Catherine Gulka - Associate Director Marketing Digital Solutions at Teva  Pharmaceuticals - Teva Pharmaceuticals | LinkedIn
Catherine Gulka - Associate Director Marketing Digital Solutions at Teva Pharmaceuticals - Teva Pharmaceuticals | LinkedIn

Rick Santelli walks off CNBC - POLITICO
Rick Santelli walks off CNBC - POLITICO

Teva stock plummets 18% after rough quarter in US generic drug market
Teva stock plummets 18% after rough quarter in US generic drug market

Teva stock plummets 18% after rough quarter in US generic drug market
Teva stock plummets 18% after rough quarter in US generic drug market

Watch CNBC's full interview with Teva Pharmaceuticals CEO Kare Schultz
Watch CNBC's full interview with Teva Pharmaceuticals CEO Kare Schultz

TevaExecutive Yitzhak Peterburg Claims Health Care Industry Is Facing Heavy  Disruption
TevaExecutive Yitzhak Peterburg Claims Health Care Industry Is Facing Heavy Disruption

The Exchange on Twitter: "Legendary investor Bill Miller told @KellyCNBC  it's still a bull market...and that there's opportunity in #value names and  #bitcoin too @B3_MillerValue @MillerValue @CNBCTheExchange @CNBC #Investing  #BTC $BTC $TEVA
The Exchange on Twitter: "Legendary investor Bill Miller told @KellyCNBC it's still a bull market...and that there's opportunity in #value names and #bitcoin too @B3_MillerValue @MillerValue @CNBCTheExchange @CNBC #Investing #BTC $BTC $TEVA

Three-Stock Lunch: AMD, HAS & TEVA
Three-Stock Lunch: AMD, HAS & TEVA

Teva CEO Sounds Off
Teva CEO Sounds Off

New Teva CEO shakes up structure and executive ranks as major layoffs loom  | Fierce Pharma
New Teva CEO shakes up structure and executive ranks as major layoffs loom | Fierce Pharma

Teva CEO Kåre Schultz discusses company's latest quarter and opioid  settlement
Teva CEO Kåre Schultz discusses company's latest quarter and opioid settlement

Teva CEO Kare Schultz on coronavirus treatment and a possible second wave
Teva CEO Kare Schultz on coronavirus treatment and a possible second wave

Watch CNBC's full interview with Teva Pharmaceuticals CEO Kare Schultz -  YouTube
Watch CNBC's full interview with Teva Pharmaceuticals CEO Kare Schultz - YouTube

CNBC on Twitter: "BREAKING: Warren Buffett's Berkshire Hathaway takes stake  in Teva Pharma.; stock jumps after-hours. https://t.co/YKho1O67Ek  https://t.co/bn0ijczjFc" / Twitter
CNBC on Twitter: "BREAKING: Warren Buffett's Berkshire Hathaway takes stake in Teva Pharma.; stock jumps after-hours. https://t.co/YKho1O67Ek https://t.co/bn0ijczjFc" / Twitter

Cramer shocked by Buffett's investment in "second-rate" Teva - Globes
Cramer shocked by Buffett's investment in "second-rate" Teva - Globes

Teva Pharma CEO: We see a stable U.S. market place for our generics -  YouTube
Teva Pharma CEO: We see a stable U.S. market place for our generics - YouTube

So These Guys Are Back on CNBC
So These Guys Are Back on CNBC

Teva to acquire Allergan for $40B
Teva to acquire Allergan for $40B

Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State

Why Warren Buffett's Berkshire Hathaway loves loathed Israeli drug stock  Teva
Why Warren Buffett's Berkshire Hathaway loves loathed Israeli drug stock Teva

Watch CNBC's full interview with Teva CEO Kåre Schultz
Watch CNBC's full interview with Teva CEO Kåre Schultz

Teva shares surge after announcing global opioid settlement
Teva shares surge after announcing global opioid settlement

Allergan to own 10% stake in Teva
Allergan to own 10% stake in Teva

You cannot critique us for trying to help,' says Teva CEO on  sustainability-linked bond launch
You cannot critique us for trying to help,' says Teva CEO on sustainability-linked bond launch

Sell Teva Pharmaceutical due to increasing generic drugs competition:  Credit Suisse
Sell Teva Pharmaceutical due to increasing generic drugs competition: Credit Suisse